Drug Shortage Report for GRANISETRON HYDROCHLORIDE INJECTION

Last updated on 2025-05-02 History
Report ID 255277
Drug Identification Number 02322765
Brand name GRANISETRON HYDROCHLORIDE INJECTION
Common or Proper name GRANISETRON HYDROCHLORIDE INJECTION
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) GRANISETRON
Strength(s) 1MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 10 x 1 mL vial / fiole
ATC code A04AA
ATC description ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2025-05-31
Actual start date
Estimated end date 2025-07-31
Actual end date
Shortage status Anticipated shortage
Updated date 2025-05-02
Company comments We are currently collaborating with Health Canada’s Drug Shortages Unit to mitigate any market impact.
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information [email protected] - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2025-05-02 French Compare
v4 2025-05-02 English Compare
v3 2025-04-22 English Compare
v2 2025-04-21 French Compare
v1 2025-04-21 English Compare

Showing 1 to 5 of 5